Our mission is to discover new medications for debilitating diseases and make them affordable to all.
New medicines… for Tuberculosis and Alzheimer’s disease.
Alzheimer’s is a serious neurodegenerative disease that leads to diminished ability to pursue daily activities. It robs the patient of their memory and creates a tremendous burden on family and caregivers. Despite many attempts, there are not yet any effective treatments for Alzheimer’s disease.
Tuberculosis is a similarly daunting problem. While commonly seen as a disease of the past, it remains the leading cause of death from infectious disease worldwide. Urgency grows as numerous strains have become resistant to current medications. New solutions for both Alzheimer’s and Tuberculosis are desperately needed.
Debilitating… physically and financially.
In 2016, an estimated 30 million patients were diagnosed with Alzheimer’s, creating a financial burden of $160 billion worldwide. With an aging population, these estimates are increasing rapidly. Alzheimer’s disease leaves individuals drained of their memory, quality of life, and financial independence.
In 2016, an estimated 10.4 million new cases of Tuberculosis were reported. Nearly 1 million of these were children living in the poorest countries, and nearly 1.7 million people total died from the disease. The current drugs take too long to work, have many side effects, and are very costly.
Affordable/Accessible… no patient should be denied.
Lgenia exists to find hope for these problems. We believe that new medicines begin their trek to patients right at the very start of discovery. The very best, highest quality medicines should be affordable and accessible to all patients. A new future begins with Lgenia – the essence of lead generation…